WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹15 Cr | ₹-32 Cr | ₹-29 Cr | ₹-17 Cr | ₹-108 Cr |
What is the latest Cash Flow from Financing Activities ratio of WANBURY ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹15 Cr |
Mar2023 | ₹-32 Cr |
Mar2022 | ₹-29 Cr |
Mar2021 | ₹-17 Cr |
Mar2020 | ₹-108 Cr |
How is Cash Flow from Financing Activities of WANBURY Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹15 Cr | Positive | |
Mar2023 | ₹-32 Cr | Negative | |
Mar2022 | ₹-29 Cr | Negative | |
Mar2021 | ₹-17 Cr | Negative | |
Mar2020 | ₹-108 Cr | - |
Compare Cash Flow from Financing Activities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹863.1 Cr | -0.8% | -12% | -8.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,666.0 Cr | -3.5% | 0% | -12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,060.0 Cr | -6.6% | -7.2% | 9.8% | Stock Analytics | |
CIPLA | ₹121,080.0 Cr | -2.8% | -5% | -7.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,605.0 Cr | -2.5% | -0.4% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,556.0 Cr | -3.8% | -0.6% | -4.2% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -0.8% |
-12% |
-8.2% |
SENSEX | -2.7% |
-0.5% |
-5.3% |
You may also like the below Video Courses